Cerity Partners
TWST icon

Cerity Partners’s Twist Bioscience TWST Stock Holding History

Cerity Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$478K Buy
10,061
+1,196
+13% +$53.6K ﹤0.01% 2323
2025
Q4 		$281K Sell
8,865
-204
-2% -$6.37K ﹤0.01% 2448
2025
Q3 		$255K Buy
+9,069
New +$275K ﹤0.01% 2390
2025
Q1 		– Sell
-6,683
Closed -$309K – 2628
2024
Q4 		$309K Sell
6,683
-1,160
-15% -$52.4K ﹤0.01% 2014
2024
Q3 		$354K Buy
+7,843
New +$373K ﹤0.01% 1957

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cerity Partners's TWST Position: Q1 2026 in Review

Cerity Partners increased its Twist Bioscience (TWST) stake by 13% in Q1 2026, buying an estimated $53.6K and bringing the position to 10,061 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Cerity Partners first reported a position in TWST in Q3 2024 and has held it in 5 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Cerity Partners held 10,061 shares of Twist Bioscience worth $478K as of Q1 2026.
  • Cerity Partners bought 1,196 Twist Bioscience shares in Q1 2026, an estimated $53.6K.
  • Twist Bioscience made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2323 holding.
  • Cerity Partners first reported a position in Twist Bioscience in Q3 2024 and has held it in 5 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.